Myocarditis following COVID-19 mRNA vaccination

Messenger RNA vaccines are the main COVID-19 vaccines authorized for use in the United States. Side effects are typically minor and transient. We report a case series of four subjects with an acute myocarditis-like illness following mRNA COVID-19 vaccination who were hospitalized at our hospital in...

Descripción completa

Detalles Bibliográficos
Autores principales: Parmar, Kanak, Mekraksakit, Poemlarp, Del Rio-Pertuz, Gaspar, Sethi, Pooja, Motes, Arunee, Hughes, Megan, Wischmeyer, Jason, Carbajal, Luis, Sosa, Erwin Argueta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Case Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607537/
https://www.ncbi.nlm.nih.gov/pubmed/35256821
http://dx.doi.org/10.1080/08998280.2021.1990743
Descripción
Sumario:Messenger RNA vaccines are the main COVID-19 vaccines authorized for use in the United States. Side effects are typically minor and transient. We report a case series of four subjects with an acute myocarditis-like illness following mRNA COVID-19 vaccination who were hospitalized at our hospital in Lubbock, Texas. Three patients were young men who presented with acute chest pain after the second dose of the mRNA-1273 vaccine. Another patient was a 53-year-old white woman who presented with acute left arm pain 3 days after the first dose of the mRNA-1273 vaccine. She was later found to have acute decompensated heart failure, and endomyocardial biopsy revealed eosinophilic injury–mediated myocarditis.

Ejemplares similares